CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 50 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,691,971 | -3.1% | 2,839,978 | +14.0% | 0.00% | – |
| Q1 2024 | $3,810,918 | +49.7% | 2,490,796 | +14.5% | 0.00% | – |
| Q4 2023 | $2,546,290 | +35.1% | 2,176,316 | +0.4% | 0.00% | – |
| Q3 2023 | $1,884,973 | -22.3% | 2,166,885 | 0.0% | 0.00% | – |
| Q2 2023 | $2,426,912 | +7.7% | 2,166,885 | 0.0% | 0.00% | – |
| Q1 2023 | $2,253,561 | -7.1% | 2,166,885 | 0.0% | 0.00% | – |
| Q4 2022 | $2,426,912 | -0.8% | 2,166,885 | +0.1% | 0.00% | – |
| Q3 2022 | $2,447,000 | -23.1% | 2,165,677 | 0.0% | 0.00% | – |
| Q2 2022 | $3,183,000 | -35.8% | 2,165,677 | 0.0% | 0.00% | – |
| Q1 2022 | $4,960,000 | -17.1% | 2,165,677 | -0.4% | 0.00% | – |
| Q4 2021 | $5,982,000 | -54.2% | 2,175,152 | -0.1% | 0.00% | – |
| Q3 2021 | $13,069,000 | +27.4% | 2,178,172 | +3.4% | 0.00% | – |
| Q2 2021 | $10,256,000 | +140.4% | 2,106,090 | +21.9% | 0.00% | – |
| Q1 2021 | $4,267,000 | -7.9% | 1,727,531 | +2.2% | 0.00% | – |
| Q4 2020 | $4,633,000 | +83.2% | 1,690,741 | +2.9% | 0.00% | – |
| Q3 2020 | $2,529,000 | -15.5% | 1,642,664 | +3.2% | 0.00% | – |
| Q2 2020 | $2,993,000 | +7.7% | 1,592,096 | -2.7% | 0.00% | – |
| Q1 2020 | $2,780,000 | -9.6% | 1,635,445 | +54.2% | 0.00% | – |
| Q4 2019 | $3,075,000 | +371.6% | 1,060,390 | +2.5% | 0.00% | – |
| Q3 2019 | $652,000 | -27.5% | 1,034,665 | +11.9% | 0.00% | – |
| Q2 2019 | $899,000 | +17.7% | 924,485 | +66.9% | 0.00% | – |
| Q1 2019 | $764,000 | +27.8% | 553,795 | -1.0% | 0.00% | – |
| Q4 2018 | $598,000 | -92.3% | 559,605 | -55.4% | 0.00% | – |
| Q3 2018 | $7,723,000 | -41.2% | 1,255,662 | +2.2% | 0.00% | -100.0% |
| Q2 2018 | $13,132,000 | +6.5% | 1,228,484 | +6.9% | 0.00% | 0.0% |
| Q1 2018 | $12,325,000 | +128.0% | 1,148,715 | +48.8% | 0.00% | – |
| Q4 2017 | $5,406,000 | -14.1% | 772,215 | +7.2% | 0.00% | – |
| Q3 2017 | $6,295,000 | -1.5% | 720,257 | +2.7% | 0.00% | – |
| Q2 2017 | $6,391,000 | +27.5% | 701,550 | +11.2% | 0.00% | – |
| Q1 2017 | $5,011,000 | -4.3% | 631,062 | +7.8% | 0.00% | – |
| Q4 2016 | $5,234,000 | -9.1% | 585,405 | +76.5% | 0.00% | – |
| Q3 2016 | $5,756,000 | – | 331,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,068,720 | $11,425,000 | 1.58% |
| AWM Investment Company, Inc. | 664,995 | $7,109,000 | 1.19% |
| NORTHPOINTE CAPITAL LLC | 816,140 | $8,725,000 | 1.16% |
| RA Capital Management | 1,525,000 | $16,302,000 | 1.06% |
| Cormorant Asset Management, LP | 1,200,000 | $12,828,000 | 0.95% |
| Virtus ETF Advisers LLC | 76,173 | $814,000 | 0.72% |
| Rock Springs Capital Management LP | 975,000 | $10,423,000 | 0.40% |
| Sofinnova Investments, Inc. | 477,524 | $5,105,000 | 0.33% |
| Perceptive Advisors | 707,581 | $7,599,000 | 0.20% |
| Crestline Management, LP | 126,652 | $1,354,000 | 0.14% |